Epic, UW Spinoffs, CDI, & More: This Week’s Wisconsin Watchlist
(Page 2 of 2)
that’s aimed at providing capital to early-stage companies, named its third “recipient” fund, which will be based in the southern part of the state. The new fund is called “Rock River Capital Partners Fund I,” and will be managed by two UW-Madison graduates with experience in startups and investing. The fund-of-funds program is structured so that a central “Badger Fund” invests in several recipient funds located around the state, which in turn inject capital into emerging businesses.
—Marquette University opened a “hub for cyber security education and research,” which it is calling the Center for Cyber Security Awareness and Cyber Defense. According to a press release, its director will be Thomas Kaczamrek, who oversees one of the Milwaukee university’s graduate computer science programs.
—John Friend joined Cellectar Biosciences as chief medical officer. Madison-based Cellectar (NASDAQ: CLRB) is developing drugs with the potential to treat malignant tumors and certain forms of blood cancer. Friend, a physician, previously spent more than seven years working in various roles at the Swiss pharmaceutical group Helsinn Therapeutics.